A safe and affordable therapeutical approach to osteoporosis... View more
More than two decades facilitating access to therapeutic recombinant proteins of thousands of patients globally... View more
Development of a technological platform for the unmet needs of highly complex cardiovascular conditions... View more
Pioneering the development of transgenic cattle for the cost efficient production of therapeutic proteins... View more
First biosimilar supported by a Pharmacovigilance Plan established according to ICH guidelines for a responsible product utilization... View more
The Company
Argentina based biotechnology company which over the past two decades has developed a global business in the supply of high quality biopharmaceuticals in the territories of Asia, Africa, Eastern Europe and Latin America.
Bio Sidus S.A. has two production sites: a plant located in Buenos Aires city, devoted to R&D activities and to the production of APIs, equipped with bacterial fermentation capacities and also hosting mass cell culture areas. Filling, lyophilization and packaging operations are conducted in separate facility located in the outskirts of Buenos Aires. A third manufacturing site is currently being refurbished to be fully FDA/EMA compliant.
View more
News | view all
October 2011
Bio Sidus will be present at the CPhI 2011, the leading pharmaceutical networking event worldwide, which will take place in Messe Frankfurt, Germany on October 25-27, 2011. Please do not miss the chance to visit us at the Argentinean Pavilion, Hall 5.1, Stand 51B20.
More news
Technology PlatformsTransgenic animals to produce therapeutic proteins
Bio Sidus has concluded is working on novel technologies for high-yield and cost-effective production of recombinant proteins for pharmaceutical applications.
| View moreAngiogenesis and muscle regeneration using the vascular endothelial growth factor.
Vascular endothelial growth factor (VEGF) is a protein that stimulates the growth of blood vessels.
White Genome Project
Yet another groundbreaking initiative for Bio Sidus is the White Genome Project, which aims to isolate, identify and characterize Antarctic bacterial strains for further sequencing of the complete genome.